Optometrists in Waterloo, IL Accepting Medicare

4 Optometrists found. Showing 1 - 4

Dr. Robert L Toal Jr., OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 742 North Market, Suite A, Waterloo, IL 62298 Phone: 618-939-4040    Fax: 618-939-3903

Dr. Jeff Cytron, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 961 N Market St, Waterloo, IL 62298 Phone: 618-939-4747

Premier Eyecare Center Pc Optometrist Medicare: Medicare Enrolled Practice Location: 742 N Market St, Suite A, Waterloo, IL 62298 Phone: 618-939-4040    Fax: 618-939-3903

Clarkson Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 204 Bradford Lane, Waterloo, IL 62298 Phone: 636-200-4393    Fax: 618-939-6037

News Archive

Genstar Capital enters definitive agreement to acquire ERT

eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

Phytochemicals are plant-derived molecules from medicinal plants that act as a prominent reservoir for treating a wide range of viral infections. In a new study, published in the journal Scientific Reports, scientists adopted a computational approach to identify Mpro inhibitors.

Northwestern Medicine receives $10 million gift to create new institute for urologic cancers

Northwestern Medicine received a $10 million gift to fund the creation of a new multidisciplinary institute dedicated to urologic cancers.

India braces for coronavirus onslaught amidst the cries of the poor

India, a nation of 1.3 billion, most of them poor, is braced to meet the coronavirus attack with a mixture of fatalism and active measures. With the 21-day lockdown announced by the Central Government from March 24, 2020, firmly in place, most citizens hesitate to step out of their houses even for perfectly legitimate needs.

Modulation Therapeutics receives MMRF grant for new multiple myeloma treatment

The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics. Since the inception of this MMRF program in 2006, $11.5 million has been committed to 12 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.

Read more Medical News

› Verified 5 days ago